ABOS vs HBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

ABOS

45.5
AI Score
VS
HBIO Wins

HBIO

47.9
AI Score

Investment Advisor Scores

ABOS

46score
Recommendation
HOLD

HBIO

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABOS HBIO Winner
Net Income -20.74M -56.70M ABOS
Operating Income -21.15M -48.58M ABOS
ROE -23.7% -412.8% ABOS
ROA -15.5% -70.8% ABOS
Total Assets 133.63M 80.07M ABOS
Cash 51.80M 8.61M ABOS
Debt/Equity 0.19 2.61 ABOS
Current Ratio 4.55 2.20 ABOS

Relative Price Performance (Last 90 Days)

ABOS 1M: -17.0% · 3M: -10.0% HBIO 1M: +0.8% · 3M: -4.4%

Current Technical Phase

ABOS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.9%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $2.15

HBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $6.10

Fundamentals Snapshot

Metric ABOS HBIO
Market Cap
Forward P/E -1.4 13.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin -318.9% 0.6%
Operating Margin 0.0% 0.0%
EPS -1.91 -2.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.